Statements (19)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
antiparasitic drug |
| gptkbp:approvedBy |
gptkb:dog
cats |
| gptkbp:ATCCode |
QP53BX10
|
| gptkbp:CASNumber |
1361129-49-6
|
| gptkbp:chemicalFormula |
C20H14Cl3N3O3S
|
| gptkbp:developedBy |
gptkb:Elanco_Animal_Health
|
| gptkbp:drugClass |
isoxazoline
|
| https://www.w3.org/2000/01/rdf-schema#label |
lotilaner
|
| gptkbp:legalStatus |
veterinary use only
|
| gptkbp:marketedAs |
gptkb:Credelio
|
| gptkbp:mechanismOfAction |
GABA-gated chloride channel antagonist
|
| gptkbp:molecularWeight |
482.8 g/mol
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:usedFor |
treatment of fleas in animals
treatment of ticks in animals |
| gptkbp:bfsParent |
gptkb:Credelio
|
| gptkbp:bfsLayer |
7
|